Varivax
NDC Package 0006-4826-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Varivax is ® is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older. Marketed by Merck Sharp & Dohme Llc, this product is identified by NDC 0006-4826 and is authorized under FDA application BLA103552.

Identification & Billing

NDC Package Code
0006-4826-00
Package Description
1 VIAL, SINGLE-DOSE in 1 CARTON / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4826-01)
Product Code
0006-4826
11-Digit Billing Format
00006482600
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 1292457 - varicella virus vaccine live (VAR) 1350 PFU in 0.5 ML Injection
  • RxCUI: 1292457 - 0.5 ML varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection
  • RxCUI: 1292457 - varicella-zoster virus vaccine live (Oka-Merck) strain 1350 PFU per 0.5 ML Injection
  • RxCUI: 1292459 - VARIVAX vaccine 0.5 ML Injection
  • RxCUI: 1292459 - 0.5 ML varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax]

Clinical Specifications

Proprietary Name
Varivax
Dosage Form
-
Usage Information
VARIVAX® is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older.

Regulatory & Marketing

Labeler Name
Merck Sharp & Dohme Llc
FDA Application #
BLA103552
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
03-17-1995
End Marketing Date
03-31-2016
Listing Expiration
03-31-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0006-4826-00 identifies a specific commercial package of 1 vial, single-dose in 1 carton / .5 ml in 1 vial, single-dose (0006-4826-01) of Varivax, labeled by Merck Sharp & Dohme Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Merck Sharp & Dohme Llc on March 17, 1995. The current certification is valid through March 31, 2016.

How is this Merck Sharp & Dohme Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00006482600. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0006-4826-00
11-Digit CMS (5-4-2)
00006-4826-00

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.